Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00056563 · ClinicalTrials.gov registry record · Phase 3
Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial
A Phase 3 study, sponsored by US Department of Veterans Affairs.
- Completed
- Registry status
- Phase 3
- Development phase
- 255
- Enrollment target
NCT00056563: Completed Phase 3 study, sponsored by US Department of Veterans Affairs.
NCT00056563 is a Phase 3 study that has completed, run by US Department of Veterans Affairs. The registered enrollment target is 255 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (67% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00056563, a Phase 3 study, has completed, sponsored by US Department of Veterans Affairs.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 255 participants
- Enrollment target
Study Summary
The goals of this study are to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's disease, and if deep brain stimulation or best medical therapy is more effective in improving Parkinson's disease symptoms
Interventions
- DEVICE Bilateral Deep Brain Stimulation
- OTHER best medical therapy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 255 participants |
| Start Date | 2002-04 |
| Est. Completion | 2008-10 |
| Phase | Phase 3 |
What the finished NCT00056563 record still lists
NCT00056563 is an interventional study that assigns participants to a tested intervention. The registered 255 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (67% lower).
The record links to 0 conditions, and to 2 interventions - of which Bilateral Deep Brain Stimulation is the first listed.
NCT00056563 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00056563 about?
NCT00056563 is a clinical study titled "Phase I Deep Brain Stimulation (DBS) vs. Best Medical Therapy (BMT) Trial". The goals of this study are to determine if simultaneous bilateral subthalamic nucleus stimulation or simultaneous bilateral globus pallidus stimulation is more effective in reducing symptoms of Parkinson's disease, and if deep brain stimulation or best medical therapy is more effective in improving...
What is the current status of trial NCT00056563?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 255 participants. The study started on 2002-04. Estimated completion is 2008-10.
What interventions are being tested in trial NCT00056563?
The interventions under investigation include: Bilateral Deep Brain Stimulation (DEVICE), best medical therapy (OTHER).
Who is sponsoring clinical trial NCT00056563?
This trial is sponsored by US Department of Veterans Affairs, which has 632 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00056563's enrollment target sits among peer trials
255 1242nd of 2000 higher than 756 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04623424 · 255 participants
Intestinal Microbiota in Stem Cell Transplant Transplant Admission
- NCT05114798 · 255 participants · NA
Time-restricted Eating Versus Daily Continuous Calorie Restriction on Body Weight and Colorectal Cancer Risk Markers
- NCT05336188 · 255 participants · Phase 2
Neurocognitive Mechanisms Underlying Smartphone-Assisted Prevention of Relapse in Opioid Use Disorder
- NCT05486637 · 255 participants · Early Phase 1
Vocal Emotion Communication With Cochlear Implants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia